Search research articles
Contact Us
Filters
Showing results (731-740 of 743) with videos related to
Page
of 75
Sort By:
Neuron
|
April 9, 2013
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease
Carlos Cruchaga, John S K Kauwe, Oscar Harari, et al.
The Lancet. Neurology
|
February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
Brian A Gordon, Tyler M Blazey, Yi Su, et al.
Neurobiology of Aging
|
January 21, 2014
Missense variant in TREML2 protects against Alzheimer's disease
Bruno A Benitez, Sheng Chih Jin, Rita Guerreiro, et al.
Scientific Data
|
July 12, 2024
Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research Center
Maria Victoria Fernandez, Menghan Liu, Aleksandra Beric, et al.
Cell
|
November 12, 2024
Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes
Jing L Guo, Dylan Braun, Gabriel A Fitzgerald, et al.
Acta Neuropathologica
|
March 2, 2017
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers
Yuetiva Deming, Zeran Li, Manav Kapoor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Basic Science and Pathogenesis
Ting-Chen Wang, Jigyasha Timsina, Chenyang Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 7, 2013
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
Tammie L S Benzinger, Tyler Blazey, Clifford R Jack, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 20, 2024
Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference
Courtney M Kloske, Michael E Belloy, Elizabeth E Blue, et al.
The Lancet. Neurology
|
March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Randall J Bateman, Yan Li, Eric M McDade, et al.
Page
of 75
Search research articles
Search
Showing results (731-740 of 743) with videos related to
Sort By:
Page
of 75
Neuron
|
April 9, 2013
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease
Carlos Cruchaga, John S K Kauwe, Oscar Harari, et al.
The Lancet. Neurology
|
February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
Brian A Gordon, Tyler M Blazey, Yi Su, et al.
Neurobiology of Aging
|
January 21, 2014
Missense variant in TREML2 protects against Alzheimer's disease
Bruno A Benitez, Sheng Chih Jin, Rita Guerreiro, et al.
Scientific Data
|
July 12, 2024
Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research Center
Maria Victoria Fernandez, Menghan Liu, Aleksandra Beric, et al.
Cell
|
November 12, 2024
Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes
Jing L Guo, Dylan Braun, Gabriel A Fitzgerald, et al.
Acta Neuropathologica
|
March 2, 2017
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers
Yuetiva Deming, Zeran Li, Manav Kapoor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Basic Science and Pathogenesis
Ting-Chen Wang, Jigyasha Timsina, Chenyang Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 7, 2013
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
Tammie L S Benzinger, Tyler Blazey, Clifford R Jack, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 20, 2024
Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference
Courtney M Kloske, Michael E Belloy, Elizabeth E Blue, et al.
The Lancet. Neurology
|
March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Randall J Bateman, Yan Li, Eric M McDade, et al.
Page
of 75